Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hannah

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Molecular and Cellular Biology|December 14, 2011
Integration of Elf-4 into stem/progenitor and erythroid regulatory networks through locus-wide chromatin studies coupled with in vivo functional validationAileen M Smith, Fernando J Calero-Nieto, Judith Schütte, et al.
Journal of Evaluation in Clinical Practice|June 18, 2014
Exploratory analysis of the relationship between home health agency engagement in a national campaign and reduction in acute care hospitalization in US home care patientsE Eve Esslinger, Charles P Schade, Cynthia K Sun, et al.
Journal of Public Health Management and Practice : JPHMP|March 21, 2023
Collateral Impacts of the COVID-19 Pandemic: The New York City ExperienceEmily G Davies, L Hannah Gould, Karolyn Le, et al.
Annals of Epidemiology|December 29, 2024
Disparities in anti-nucleocapsid and anti-spike SARS-CoV-2 antibody prevalence in NYC - April-October 2021Anne Schuster, Erik J Kopping, Jo-Anne Caton, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2017
Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancerHeinz-Josef Lenz, Philip Philip, Mark Saunders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2009
Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006L Hannah Gould, Linda Demma, Timothy F Jones, et al.
Leukemia|January 30, 2010
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemiaJ E Lancet, I Gojo, M Burton, et al.
Nature Cell Biology|April 2, 2020
Single-cell chromatin accessibility maps reveal regulatory programs driving early mouse organogenesisBlanca Pijuan-Sala, Nicola K Wilson, Jun Xia, et al.
American Journal of Epidemiology|September 22, 2024
Risk factors for Lyme disease among residents of rural, suburban, and urban areas in the United States: A Case-Control StudyL Hannah Gould, Rebecca Fee, John White, et al.
Gynecologic Oncology|September 23, 2017
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancerG Rustin, I Vergote, J P Micha, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Molecular and Cellular Biology|December 14, 2011
Integration of Elf-4 into stem/progenitor and erythroid regulatory networks through locus-wide chromatin studies coupled with in vivo functional validationAileen M Smith, Fernando J Calero-Nieto, Judith Schütte, et al.
Journal of Evaluation in Clinical Practice|June 18, 2014
Exploratory analysis of the relationship between home health agency engagement in a national campaign and reduction in acute care hospitalization in US home care patientsE Eve Esslinger, Charles P Schade, Cynthia K Sun, et al.
Journal of Public Health Management and Practice : JPHMP|March 21, 2023
Collateral Impacts of the COVID-19 Pandemic: The New York City ExperienceEmily G Davies, L Hannah Gould, Karolyn Le, et al.
Annals of Epidemiology|December 29, 2024
Disparities in anti-nucleocapsid and anti-spike SARS-CoV-2 antibody prevalence in NYC - April-October 2021Anne Schuster, Erik J Kopping, Jo-Anne Caton, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2017
Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancerHeinz-Josef Lenz, Philip Philip, Mark Saunders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2009
Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006L Hannah Gould, Linda Demma, Timothy F Jones, et al.
Leukemia|January 30, 2010
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemiaJ E Lancet, I Gojo, M Burton, et al.
Nature Cell Biology|April 2, 2020
Single-cell chromatin accessibility maps reveal regulatory programs driving early mouse organogenesisBlanca Pijuan-Sala, Nicola K Wilson, Jun Xia, et al.
American Journal of Epidemiology|September 22, 2024
Risk factors for Lyme disease among residents of rural, suburban, and urban areas in the United States: A Case-Control StudyL Hannah Gould, Rebecca Fee, John White, et al.
Gynecologic Oncology|September 23, 2017
A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancerG Rustin, I Vergote, J P Micha, et al.
Pageof 21